Capchem files updated prospectus with HKEX; electronics chemicals and functional materials provider with CITIC Securities and CICC as joint sponsors

NewTimeSpace News: On 28 August 2026, Shenzhen Capchem Technology Co., Ltd. filed an updated prospectus with HKEX, with CITIC Securities and CICC acting as joint sponsors. The Company is a China-headquartered provider of electronic chemicals and functional materials, principally engaged in the research, development, production and sale of battery chemicals, organic fluorochemicals and electronic information chemicals, providing comprehensive solutions to customers in industries including new energy vehicles (NEV), energy storage systems (ESS), consumer electronics, AI and digital infrastructure, semiconductor manufacturing, pharmaceuticals and other advanced industrial applications, with full-chain capabilities spanning "concept, design, development, validation, mass production and continuous optimization" and 13 production bases as of the last practicable date.

The Company was founded in 2002, with its predecessor traceable to Shenzhen Zhoubang Chemical Co., Ltd., established by the founding team in 1996. With nearly three decades of industry experience, its business has expanded from early capacitor chemicals into three business segments: battery chemicals, organic fluorochemicals and electronic information chemicals.

The Company continues to increase R&D investment, enhancing technology and product capabilities vertically while broadening product categories horizontally, and by integrating the capabilities of its three business segments in technology development, manufacturing execution and customer collaboration, it shares platform resources, transfers expertise and deepens customer relationships across application areas and business segments, achieving more efficient product iteration, more comprehensive solution coverage and faster business expansion.

In terms of sales, the Company primarily adopts a direct sales model, supplemented by sales through trading companies; direct sales accounted for approximately 90% of the Company's revenue in 2023, 2024 and 2025 and for the six months ended 30 June 2026 respectively, while sales to trading companies accounted for 10.6%, 13.4%, 9.8% and 7.1% in the respective periods.

NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.